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INTRODUCTION
Otitis media with effusion (OME) is one of the most common dis-
eases in infants and children, with more than 90% of children expe-
riencing OME before reaching school age (1, 2). About 2.2 mil-
lion diagnosed episodes of OME occurs annually in the United
States, and more than one million operations are performed (3).
As a result, many children suffer from OME, and the medical cost
is very high. Nevertheless, fundamental treatment and prevention
of OME have not yet been completely determined. If OME is not
adequately treated, then resultant hearing difficulty can cause
delayed language development, intellectual disorders, and com-
munication problems (2, 3).
The etiologies of OME are very diverse and include viral and
bacterial infection, Eustachian tube dysfunction, and excessive
exudate production due to allergy and chronic inflammation (4, 5).
Therefore, management of OME varies depending on the patient
and the clinician, and such management may be pursued through
observation, antibiotic therapy, or ventilation tube (VT) inser-
tion (3, 4, 6, 7). There is considerable debate among physicians
concerning the treatment principles of OME: are antibiotics or
antihistamines necessary? How long should antibiotics be used?
When is VT insertion needed?
Recently, new evidence-based recommendations have been
introduced for the diagnosis and management of OME in children
(8, 9). These are presently the best guidelines, based on the analy-
sis of results selected from many studies. The updated 2004 guide-
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Original Articlelines offer several recommendations, including watchful waiting
for three months, and issue recommendations related to the avoid-
ance of antihistamines, decongestants, antimicrobials, and corticos-
teroids (9). In addition, the subcommittee has stated that the guide-
lines are designed to assist primary care physicians and has empha-
sized the significance of documentation related to laterality, dura-
tion of effusion, and presence and severity of associated symp-
toms, in the interest of facilitating communication between refer-
ring primary care clinicians and specialists (9). However, there
are some difficulties in following the general guidelines in the
tertiary hospital setting, because referred children have often been
treated with medications already, and they may also have aller-
gies and sinusitis (10-12). Furthermore it is often hard to make
decisions related to further management, including VT insertion,
because of imprecise information and documentation (12). In the
present study, we tried to apply the guidelines to referred chil-
dren with OME and to evaluate the efficiency of antibiotics and
antihistamines in the management of OME in a tertiary hospital
setting. 
MATERIALS AND METHODS
One hundred children with OME diagnosed by pneumatic oto-
scopy, tympanography, and pure tone audiography in the ter-
tiary Ajou University Hospital (Suwon, Korea), between June
2003 and March 2005, were enrolled in this consecutive, random-
ized study. The Institutional Review Board of the Ajou University
School of Medicine (Suwon, Korea) approved the study protocol.
The diagnosis of OME was limited to patients showing B or C
type on tympanometry and exhibiting hearing loss greater than
25 dB on pure tone audiometry. Patients with acute otitis media
(AOM) and fever or otalgia were excluded from the study. We
also excluded children with cleft palates, developmental difficul-
ties, contraindications to medications, and follow-up loss. All
patients were diagnosed by one experienced otologist. Sixteen of
100 children were lost to follow-up, so 84 children were even-
tually included in the analysis. There were 57 boys and 27 girls,
and the average age was 69.0 months (range, 5 months-12 yr).
These patients were randomized to receive five different kinds
of treatment for two weeks, regardless of antibiotic/antihistamine/
steroid medication history. After obtaining consent from parents
or guardians, we consecutively and randomly prescribed an antibi-
otic, amoxicillin-clavulanate syrup (1 cc/kg, Augmex Duo syrup
�,
Korea United Parma. INC., Seoul, Korea), in Group I (n=16); a
combination of an antibiotic and a steroid, prednisolone (1 mg/
kg, Solondo
�, Yuhan corp., Seoul, Korea), in Group II (n=18); a
combination of an antibiotic and an antihistamine, ebastine (0.2
cc/kg, Ebastel
�, Boryung INC., Seoul, Korea), in Group III (n=
15); a combination of an antibiotic, a steroid, and an antihistamine
in Group IV (n=17); and a mucolytic ivy leaf extract (0.5 cc/kg,
Prospan syrup
�, Ahn-Gook Pharm corp., Seoul, Korea) alone
in Group V (n=17). We used the mucolytics as a control. 
In the present study, amoxicillin-clavulanate was used as the
basic antibiotic medication for patients with OME visiting the
tertiary hospital, while considering previous history of antibiotic
use and possibility of organism resistance to first-line antibiotics.
Ampicillin and amoxicillin are the first-line medications usually
used for treatment of OME in local primary clinics in Korea. Am-
oxicillin-clavulanate is also frequently used in local clinics for treat-
ing patients with long histories of OME, because it is effective in
treating β -lactamase producing bacteria. 
The children were followed up every 2 weeks, tympanometry
and pure tone audiometry were obtained, and decisions were made
regarding cure, observation, or operation, based on the usual
recommendations. VT insertion was performed to patients with
hearing loss greater than 40 dB, in patients with bilateral OME
for greater than three months, and in patients with unilateral OME
for greater than six months. We observed patients whose hear-
ing loss was less than 40 dB for three months if bilateral OME
was present and for six months if unilateral OME was present.
The values are presented as means±standard deviations (SD).
Statistical analyses were performed using a Pearson chi square
test. P<0.05 were considered statistically significant.
RESULTS 
Clinical characteristics of children with OME visiting a
tertiary hospital (Table 1)
The mean sustained period (past history) of OME after the first
attack was 12.9±12.3 months, and the mean duration of recent
OME occurring just before visiting our hospital was 10.5±14.8
weeks. The mean duration of medical therapy for OME was 5.1
±6.2 weeks, and the mean frequency of upper respiratory infec-
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Table 1. Clinical characteristics of children with OME visiting the
tertiary hospital (n=84)
Average±standard deviation.
OME: otitis media with effusion; URI: upper respiratory infection.
Average age 69.0 months (range; 5 months-12 yr)
Sex 57 males:27 females
Past sustained period of OME 12.9±12.3 months
Duration of recent OME 10.5±14.8 weeks
Medication history for OME 5.1±6.2 weeks
Frequency of URI 2.9±1.6 times/6 months
Bilaterality of OME 68 (81.0%) bilateral:16 (19.0%) unilateral
Pure tone average Right: 26.1±11.3 dB/22.1±13.6 dB
(air conduction threshold/ Left: 26.4±11.0 dB/23.8±12.1 dB
air-bone gap)
Number of children showing 34/84 (40.5%)
allergic symptoms
Number of children showing 17/40 (47.6%)
positive allergic skin testsChoung Y-H et al.: Management for OME in the Tertiary Hospital 203
tions (URI) was 2.9±1.6 times per six months. There were no
significant differences among the five groups with regard to dura-
tion of recent OME, medication history, or frequency of URIs
(P>0.05).
Sixty-eight patients (81.0%) had bilateral OME, and 16 patients
(19.0%) had unilateral OME. At the time of referral to our hos-
pital, the air conduction threshold and the air-bone gap were
26.1±11.3 dB and 22.1±13.6 dB on the right side and 26.4±
11.0 dB and 23.8±12.1 dB on the left side, respectively. 
Thirty-four (40.5%) patients exhibited two or more allergic
symptoms, including itching, sneezing, nasal obstruction, or watery
rhinorrhea. We found no allergic symptoms in 46 (54.8%) patients.
Four children (9.5%) had insufficient information concerning
allergies. Forty children (47.6%) who were suspected of having
allergies underwent allergic skin tests. Seventeen (42.5%) of these
children exhibited positive responses, and 23 (57.5%) exhibited
negative responses. 
Results of the management of OME 
Thirty-six (42.9%) of 84 children resolved over a mean period of
6.9 weeks after initiation of treatment. Thirty-six children (42.9%)
were treated with VT insertion, and 12 children (14.3%) were
continuously observed (Fig. 1). Groups I, II, III, IV, and V showed
resolution rates of 50.0%, 44.4%, 40.0%, 29.4%, and 47.1%,
respectively. The OME resolution rates were no different among
the groups (P>0.05). The ventilation tube insertion rates were
25.0% in group I, 44.4% in group II, 46.7% in group III, 58.8%
in group IV, and 41.2% in group V (Fig. 2).
We analyzed whether allergic symptoms or positive skin tests
affected the prognosis of OME. However, we found no significant
differences in the resolution rates for the allergic group (n=42)
and the non-allergic group (n=38) (Fig. 3A). There were no dif-
ferences in the resolution rates for the groups (n=42) with aller-
gic symptoms or positive skin test responses, when steroids (group
II), antihistamines (group III), steroids and antihistamines (group
IV), or other medications (group I and V) were used (P>0.05)
(Fig. 3B).
Regarding the management of OME according to laterality,
56.3% of children with unilateral OME (n=16) experienced res-
olution, a figure statistically higher than the 39.7% resolution
rate seen in bilateral OME (n=68) (P=0.000) (Fig. 4).
DISCUSSION
OME is defined as the presence of fluid in the middle ear with-
out signs or symptoms of acute ear infection. It can be detected
on routine screening tests, and it can be diagnosed using AOM.
There is considerable debate concerning the treatment of OME
because patients generally do not have severe symptoms, and
diverse treatment trials show conflicting results. Therefore, prac-
tical guidelines for aiding the diagnosis and treatment of OME
children, aged 2 months to 12 yr, have been developed by experts
in the fields of primary care, otolaryngology, infectious disease,
epidemiology, hearing, speech and language, and advanced prac-
tice nursing (8, 9).
Specifically, the 2004 guidelines offer 11 evidence-based state-
ments and divide treatment into four groups based on clinical
presentation: strong recommendation, recommendation, option,
and no recommendation (9). According to these guideline, VT
insertion is recommended in children with OME after three to six
months of watchful waiting. This recommendation is based on
the notion that OME often resolves spontaneously. Approximately
90% of cases resolve by three months (13), and only 5-10% per-
sist for more than one year (1, 14). In the present study, we tried
to apply watchful waiting as long as possible, following the guide-
lines. However, the total resolution rate after two weeks of med-
Fig. 1. The management of OME in children visiting the tertiary hospital.
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Fig. 2. The management of OME in children visiting the tertiary hospi-
tal according to five different protocols. There was no difference in the
resolution rates of OME among the groups (chi-square test, P>0.05).
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)ication and watchful waiting was only 42.9%. This figure was
much lower than we expected. Actually, we could not avoid per-
forming VT insertion in 36 patients (42.9%) because of prolonged
or severe hearing loss or speech problems. These results indicate
that the natural resolution rate of OME in children who visit a
tertiary hospital is very low and that some patients may be refrac-
tory to early treatments such as short-term medical therapy in
the tertiary hospital setting in South Korea.
Consequently, the following guideline amendments seem to be
appropriate. Clinicians should look for children with OME who
are at risk for speech, language, or learning problems and should
promptly evaluate hearing, speech, language, and need for inter-
vention in these patients (9). We believe prompt, precise evalu-
ation can help clinicians determine the appropriate approach to
referred patients, thus avoiding unnecessary watchful waiting. It
should be mentioned that the guidelines are not intended as a sole
source of guidance in evaluating children with OME (9).
Therefore, it is very important to have precise information and
documentation from primary care clinicians, as the guidelines
already emphasize. Primary care doctors should provide doctors
in the tertiary hospitals with information concerning effusion dura-
tion, specific reasons for referral, and additional relevant infor-
mation, such as history of AOM and developmental status of the
child. However, in many patients with OME, the information is
not delivered correctly or in detail, but is given only by the patient’s
parent or caregiver. Therefore, specialists treating OME in the
tertiary hospital need to develop a form and referral system con-
necting them with the primary care clinicians. 
Evidence-based recommendations indicate that antihistamines
and decongestants are generally ineffective for the treatment of
OME and are therefore not recommended. Furthermore, antimi-
crobials and corticosteroids do not have long-term efficacy and
are not recommended for routine management (8, 9). However,
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Fig. 4. The management of OME according to the laterality. Children
with unilateral OME showed better resolution rate than bilateral (chi-
square test, P=0.000).
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Fig. 3. The management of OME according to allergy. (A) Allergic symptoms or signs did not affect the progress of OME (chi-square test, P>0.05).
(B) There was no difference in the resolution rate of OME among groups, using steroids (group II), antihistamines (group III), steroids and anti-
histamines (group IV), or other drugs (group I and V) to manage the children showing allergic symptoms or signs (linear by linear association of
chi-square test, P>0.05). 
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B A Resolutionwe believe these recommendations are more applicable in the
primary care setting, not in referred patients with severe or pro-
longed symptoms. In fact, most referred children have already
received many medications, including antibiotics, and many of
them have a history of allergic rhinitis and sinusitis. Therefore,
we prospectively designed and applied five different protocols
made up of different combinations of antibiotics, antihistamines,
and corticosteroids, in the interest of identifying their effective-
ness. There were no statistically significant differences among
the five groups (P>0.05). In addition, children with allergic symp-
toms or signs in the present study showed no significant respons-
es to antihistamines or corticosteroids (P>0.05). These findings
are in agreement with the 2004 clinical practice guidelines for the
treatment of OME (6, 9, 15, 16).
Concerning the management of OME according to laterality,
children with unilateral OME in the present study had better prog-
nosis than those with bilateral OME (P=0.000). Furthermore,
children with unilateral AOM were cured more rapidly than were
those with bilateral AOM (17). Other reports have shown that
the risk of a prolonged course is twice as high in children <2 yr
of age with bilateral AOM than in children ≥2 yr of age with
unilateral AOM (18). However, some reports have claimed that
laterality has no effect on the prognosis of OME (19, 20). In the
acute stage, unilateral otitis media resolves more quickly than
does bilateral otitis media, but the resolution rate of OME decreas-
es abruptly as time passes, regardless of laterality (19, 20). How-
ever, in the present study, unilateral OME had a higher resolu-
tion rate than did bilateral OME, even though the OME was long-
term in nature.
Referred children with OME may require prompt VT insertion.
However, we could not pinpoint any factors suggesting prompt
or delayed VT insertion, except for laterality. It is highly likely
that the duration of OME and medical therapy are important in
determining surgical options. Further studies are needed. 
CONCLUSIONS
In the tertiary hospital setting, the resolution rate of OME in chil-
dren was not as high as anticipated, and antibiotics and anti-aller-
gic medications proved to be no more effective than controls for
the management of OME. This low resolution rate might be attrib-
utable to the pre-treatment characteristics of studied children,
such as extended history of OME. Further guidelines, such as those
for early VT insertion, may be required in the management of
referred children with OME in the tertiary hospital setting. In
addition, the importance of meticulous documentation should be
emphasized to primary physicians referring pediatric patients
with OME.
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